Abstract
Mammalian cells proteolytically release (shed) the extracellular domains of many cell-surface proteins1. Modification of the cell surface in this way can alter the cell's responsiveness to its environment2 and release potent soluble regulatory factors3. The release of soluble tumour-necrosis factor-α (TNF-α) from its membrane-bound precursor4,5 is one of the most intensively studied shedding events because this inflammatory cytokine is so physiologically important6,7. The inhibition of TNF-α release (and many other shedding phenomena) by hydroxamic acid-based inhibitors indicates that one or more metalloproteinases is involved3,8,9. We have now purified and cloned a metalloproteinase that specifically cleaves precursor TNF-α. Inactivation of the gene in mouse cells caused a marked decrease in soluble TNF-α production. This enzyme (called the TNF-α-converting enzyme, or TACE) is a new member of the family of mammalian adama-lysins (or ADAMs)10, for which no physiological catalytic function has previously been identified. Our results should facilitate the development of therapeutically useful inhibitors of TNF-α release, and they indicate that an important function of adamalysins may be to shed cell-surface proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rose-John, S. & Heinrich, P. C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281–290 (1994).
Walcheck, B. et al. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380, 720–723 (1996).
Mohler, K. M. et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218–220 (1994).
Decker, T., Lohmann-Matthes, M. L. & Gifford, G. E. Cell-associated tumour necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138, 957–962 (1987).
Kriegler, M., Perez, C., De Fay, K., Albert, I. & Lu, S. D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53, 45–53 (1988).
Bazzoni, F. & Beutler, B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334, 1717–1725 (1996).
Sherry, B. & Cerami, A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J. Cell Biol. 107, 1269–1277 (1988).
McGeehan, G. M. et al. Regulation of tumour-necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370, 558–561 (1994).
Gearing, A. J. et al. Processing of tumour-necrosis factor-α precursor by metalloproteinases. Nature 370, 555–557 (1994).
Wolfsberg, T. G. & White, J. M. ADAMs in fertilization and development. Dev. Biol. 180, 389–401 (1996).
Black, R. A. et al. Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP-insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophys. Res. Commun. 225, 400–405 (1996).
Stocker, W. et al. The metzincins—topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4, 823–840 (1995).
Howard, L., Lu, X., Mitchell, S., Griffiths, S. & Glynn, P. Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem. J. 317, 45–50 (1996).
Cerretti, D. P. et al. Molecular cloning of the interleukin-1β converting enzyme. Science 256, 97–100 (1992).
Woessner, J. F. Jr Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145–2154 (1991).
Barr, P. J. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66, 1–3 (1991).
Teeter, M. M., Roe, S. M. & Heo, N. H. Atomic resolution (0.83 A) crystal structure of the hydrophobic protein crambin at 130K. J. Mol. Biol. 230, 292–311 (1993).
Wolfsberg, T. G. et al. The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional, and evolutionary implications. Proc. Natl Acad. Sci. USA 90, 10783–10787 (1993).
Yoshida, S., Setoguchi, M., Higuchi, Y., Akizuki, S. & Yamamoto, S. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int. Immunol. 2, 585–591 (1990).
Krätzschmar, J., Lum, L. & Blobel, C. P. Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J. Biol. Chem. 271, 4593–4596 (1996).
Yagami-Hiromasa, T. et al. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377, 652–656 (1995).
Weskamp, G., Krätzschmar, J., Reid, M. S. & Blobel, C. P. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell. Biol. 132, 717–726 (1996).
McMahan, C. J. et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 2821–2832 (1991).
Peschon, J. J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955–1960 (1994).
Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A. & Seidman, J. G. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12, 2391–2395 (1992).
Dexter, T. M., Allen, T. D. & Lajtha, L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. 91, 335–344 (1976).
Snell, W. J. & White, J. M. The molecules of mammalian fertilization. Cell 85, 629–637 (1996).
Libby, P., Alroy, J. & Pereira, M. E. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J. Clin. Invest. 77, 127–135 (1986).
Warner, S. J. & Libby, P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol 142, 100–109 (1989).
Meier, T., Arni, S., Malarakannan, S., Poincelet, M. & Hoessli, D. Immunodetection of biotinylated lymphocyte-surface proteins by enhanced chemiluminescence: a nonradioactive method for cell-surface protein analysis. Anal. Biochem. 204, 220–226 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Black, R., Rauch, C., Kozlosky, C. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729–733 (1997). https://doi.org/10.1038/385729a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/385729a0
This article is cited by
-
Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNF
Nature Immunology (2023)
-
Overexpression of transmembrane TNFα in brain endothelial cells induces schizophrenia-relevant behaviors
Molecular Psychiatry (2023)
-
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review
Oncogene (2023)
-
Omega-3 Polyunsaturated Fatty Acids Protect Neurological Function After Traumatic Brain Injury by Suppressing Microglial Transformation to the Proinflammatory Phenotype and Activating Exosomal NGF/TrkA Signaling
Molecular Neurobiology (2023)
-
Phylogeny and expression of ADAM10 and ADAM17 homologs in lamprey
Fish Physiology and Biochemistry (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.